Cargando…

MON-LB102 Liquid L-Thyroxine Can Maintain Stable TSH Values in Patients with Hypothyroidism: A Prospective Study

In patients treated for hypothyroidism, the usual practice is to monitor TSH values yearly once a therapeutic dosage of levothyroxine (L-T4) is determined. No consistent data are present in literature about the stability of TSH levels in patients (without malabsorption) treated with liquid L-T4, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fallahi, Poupak, Ferrari, Silvia Martina, Elia, Giusy, Ragusa, Francesca, Paparo, Sabrina Rosaria, Patrizio, Armando, Mazzi, Valeria, Antonelli, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550900/ http://dx.doi.org/10.1210/js.2019-MON-LB102

Ejemplares similares

PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

FRI487 Oral Liquid L- Thyroxine (L-T4) Is More Effective In Controlling Hypothyroidism, Than L-T4 Tablet, In Patients Submitted To Total Thyroidectomy
por: Fallahi, Poupak, et al.
Publicado: (2023)

MON-625 Serum Tsh Levels Normalisation In Patients With Celiac Disease After The Switch From Oral L-t4 In Tablet Form To L-t4 In Liquid Formulation
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed in Comparison to L-T4 Tablets in Patients With Lactose Intolerance
por: Fallahi, Poupak, et al.
Publicado: (2021)

FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2023)

MON-564 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With L-thyroxine (L-T4) In Soft Gel Capsule Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

MON-565 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With Oral Liquid L-thyroxine (L-T4) Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)

MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2021)

MON-566 Early Diagnosis of Lymph Node Metastases by Serum Tg and Neck Ultrasonography, and Long Term Follow Up After Radioiodine and/or Surgical Treatment in Patients with Papillary or Follicular Thyroid Cancer.
por: Fallahi, Poupak, et al.
Publicado: (2019)

MON-614 Lipid Profile In Patients With Primary Hypothyroidism: Does TSH Values Make A Difference?
por: Martins Machado, Catarina, et al.
Publicado: (2019)

MON-601 Optimizing the Mean TSH Target Range for Thyroid Hormone (L-T4) Replacement in Primary Hypothyroidism
por: Siddiqui, Mahwash, et al.
Publicado: (2019)

Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
por: Patrizio, Armando, et al.
Publicado: (2022)

Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study
por: Fallahi, Poupak, et al.
Publicado: (2018)

Evaluation of the Optimal Thyroxine Levels for Thyroxine Hormone Replacement in Patients With Central Hypothyroidism
por: Lee, Ka Fai, et al.
Publicado: (2021)

MON-LB87 Recombinant Human TSH vs Thyroid Hormone Withdrawal Preparation for Radioiodine Ablation in Pediatric Differentiated Thyroid Cancer
por: Schumm, Max A, et al.
Publicado: (2020)

SUN-LB102 Uncommon Pathology of Neck Mass
por: Alzenaidi, Ahlam, et al.
Publicado: (2019)

MON-LB094 Matrix Metalloproteinases Are Linked with Preeclampsia and May Be Useful as a Biomarker in Gestational Subclinical Hypothyroidism
por: Harumy de Lima Hirata, Andrea, et al.
Publicado: (2019)

ODP511 Relationship between TSH and Free Thyroxine in Outpatient Cancer Patient Population
por: Li, Jieli, et al.
Publicado: (2022)

Chemokines in hyperthyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

MON-597 Association of Serum TSH with Atrial Fibrillation in the Elderly
por: Kravchenko, Maria, et al.
Publicado: (2019)

SAT-LB78 TSH Is a Negative Modulator of Hippo Transcriptional Effectors
por: Fernández-Méndez, Celia, et al.
Publicado: (2020)

SAT-LB89 Choriocarcinoma Induced Hyperthyroidism: Molecular Mimicry Between HCG and TSH
por: Ankireddypalli, Anvitha Reddy, et al.
Publicado: (2020)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

SAT-553 Gut Microbiota Involved in Thyroxine Metabolism and Development of Subclinical Hypothyroidism
por: Bo, Tao, et al.
Publicado: (2019)

MON-LB75 Stratifying the Risk of Malignancy in Indeterminate Thyroid Nodules
por: Imam, Shahnawaz, et al.
Publicado: (2020)

MON-582 The Natural History of Delayed TSH Elevation in Neonatal Intensive Care Newborns
por: Zung, Amnon, et al.
Publicado: (2019)

SAT-LB102 When the Answer Is Not in the First Look: An Unusual Presentation of Follicular Thyroid Carcinoma
por: Bernabe Ramirez, Carolina, et al.
Publicado: (2019)

MON-599 Physician Reported Challenges in the Management of Hypothyroidism
por: Esfandiari, Nazanene Helen, et al.
Publicado: (2019)

MON-618 National In-Hospital Trends in Acquired Hypothyroidism
por: Kumar, Monisha Priyadarshini, et al.
Publicado: (2019)

SAT-LB79 Biotin Depleting Procedure Does Not Impact the Reliability of TSH, LH and FSH Immunoassays
por: Gruson, Damien, et al.
Publicado: (2020)

MON-588 Characteristics of Overt Thyrotoxicosis When TSH Is Measured in All Patients in Nonsurgical Departments
por: Bashkin, Amir, et al.
Publicado: (2019)

MON-LB095 Thyroid Nodule Localization as a Predictor Factor for Malignancy
por: Sibai, Zakaria, et al.
Publicado: (2019)

MON-LB101 Pharmacokinetics of Liothyronine during Thyroid Hormone Therapy Withdrawal
por: Celi, Francesco, et al.
Publicado: (2019)

MON-LB77 Inhibitors of XIAP as Novel Therapeutic Agents in Thyroid Cancer
por: Chu, Simon, et al.
Publicado: (2020)

MON-LB78 Thyroid Nodules > 4cm: High-Risk for Malignancy or Not?
por: Fishel, Heather, et al.
Publicado: (2020)

MON-602 Improving The Accuracy And Reliability Of Free Thyroxine Measurements Through The CDC Clinical Standardization Programs
por: Ribera, Ashley, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_all09h1ej9ltbihlnu5o4biitk